Last reviewed · How we verify
NCT05196451: SIPCOV
Short-time Intervention in Post-Covid Syndrome Syndrome (SIPCOV): A Pragmatic Randomised Controlled Trial
NA trial testing Rehabilitation based on CBT principles in COVID-19 in 314 participants. Completed in 30 April 2024.
1 December 2023
Quick facts
| Lead sponsor | University Hospital, Akershus |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 314 |
| Start date | 21 February 2022 |
| Primary completion | 1 December 2023 |
| Estimated completion | 30 April 2024 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Rehabilitation based on CBT principles
Conditions studied
- COVID-19 — all drugs for COVID-19 →
Sponsor
University Hospital, Akershus
Who can join
16 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study is a 2-arm pragmatic randomised controlled trial (RCT) in which 310 patients who suffer from post-Covid syndrome are randomised to either a short-time outpatient-based rehabilitation program (the intervention) or care as usual in a 1:1 ratio. Assessments will take place immediately before randomisation (T0), after intervention or care as usual (T1), and 6 months after T1 (T2). Patients will be recruited from General Practitioners (GP's) as well as social media and self-referral to the involved institutions.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Brief Outpatient Rehabilitation Program for Post-COVID-19 Condition: A Randomized Clinical Trial.
Nerli TF, Selvakumar J, Cvejic E, Heier I, et al · · 2024 · cited 18× · PMID 39699896 · DOI 10.1001/jamanetworkopen.2024.50744 -
Applicability and adaptation of cognitive behavior therapy for long COVID neuropsychiatric symptoms: a review with insights from ME/CFS.
Takamatsu N, Kuga H. · · 2025 · cited 1× · PMID 41073921 · DOI 10.1186/s12879-025-11754-0 -
Cost-effectiveness of a brief cognitive-behavioral outpatient rehabilitation program for patients with post-COVID-19 condition within a pragmatic randomized controlled trial.
Nerli TF, Selvakumar J, Heier I, Johnsen TL, et al · · 2026 · PMID 42032661 · DOI 10.1186/s12962-026-00748-7
Verify or expand the search:
- PubMed search for NCT05196451
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other University Hospital, Akershus trials
Trials by the same sponsor.
- NCT06865027 — The Effect of Arterial Carbon Dioxide Levels on Cerebral Blood Flow and Cerebral Autoregulation in the Steep Trendelenbu · NA · enrolling by invitation
- NCT06721754 — Diabetes Related Foot Ulcers with Negative Pressure Wound Therapy · NA · recruiting
- NCT06731985 — The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes. · recruiting
- NCT06576752 — Management of Patients with Heart Failure At Home After Hospital Discharge · NA · recruiting
- NCT06032715 — Brief Intervention for Sleep Medication Misuse Among Elderly · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05196451 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Akershus
- Last refreshed: 30 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05196451.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing